AI and Machine Learning Redefine Gastrointestinal Disorder Detection

Updated May 29, 2025

Artificial intelligence and machine learning are poised to transform how gastrointestinal disorders are managed. Colonoscopies, a success story in⁢ modern medicine, effectively detect cancer early, reducing mortality. However, colorectal cancer remains the⁤ third leading cause of cancer-related deaths in the U.S.

Researchers are exploring whether AI can improve the⁢ detection ⁢of colorectal cancer and related ⁢ gastrointestinal disorders. One challenge⁤ lies in differentiating between similar-looking disorders at the cellular level. ⁢As an example, deep learning algorithms ‍analyze biopsy slides to distinguish environmental enteropathy from ‍celiac disease. A study by Syed et al.achieved 93.4% accuracy in⁢ differentiating these ‍conditions using neural networks.

The study also identified biomarkers like interleukin 9 and interleukin 6, aiding accurate diagnoses. This machine learning approach could reduce the need for multiple biopsies and endoscopic procedures, streamlining patient care.

Randomized controlled trials support the use of machine learning in⁣ gastroenterology. A Chinese study, in collaboration with Beth Israel Deaconess Medical Center and Harvard Medical School, tested a convolutional neural network⁢ to improve⁢ the detection of precancerous colorectal polyps during colonoscopies. The adenoma detection rate was higher in the machine learning-assisted group (29.1% vs. 20.3%).

Nayantara Coelho-prabhu,M.D.,a⁣ gastroenterologist at Mayo Clinic,points out,however,that the ⁤clinical relevance of detection of diminutive polyps remains to be determined. “Yet, ⁣there is definite clinical importance in the subsequent progress of computer assisted diagnosis (CADx) or polyp characterization algorithms. These⁢ will help clinicians determine clinically relevant polyps,and possibly advance the resect and discard practise. It also will help clinicians adequately assess margins of polyps, so that complete removal can be achieved, thus⁣ decreasing⁣ future recurrences.”

The WISENSE system, combining a convolutional ⁢neural network with deep reinforcement learning, reduces blind spots during endoscopy⁤ of the esophagus, stomach, and duodenum. A randomized controlled trial showed a lower blind spot rate in the WISENSE group (5.86% vs 22.46%).

Mayo ⁤Clinic’s Endoscopy Center is exploring machine learning in ⁣GI care using Endonet,a library of ⁤endoscopic videos and images linked to clinical data. This resource includes full-length videos and summaries with landmarks and abnormalities.

Dr. Coelho-Prabhu explains that the idea is to have different‍ user interfaces: ⁢“From the ⁢patient’s perspective, it will serve as an electronic video record of all their procedures, and future procedures can be tailored to survey prior abnormal⁢ areas as needed. From a research perspective, this will be a diverse and rich ⁤library including large volumes of specialized populations such as Barrett’s esophagus, inflammatory bowel disease, familial polyposis syndromes. The additional strength is‍ that Mayo Clinic provides highly specialized care, especially to these select populations. We can develop AI algorithms to advance medical care using this library. From a hospital system perspective, this would serve ⁢as a reference library, guiding endoscopists, including ⁣for advanced therapeutic procedures in the future. it also could be used to measure and monitor quality indicators in endoscopy. From an⁣ educational standpoint, this library can be developed into a teaching⁤ set for both trainee and advanced ⁤practitioners looking for CME opportunities. From ⁣industry perspective, this database could be used to train/validate commercial AI‍ algorithms.”

What’s next

While AI and machine learning may ⁢not be a cure-all, they are becoming vital tools in personalized patient care, offering ⁢new avenues ‍for improved diagnostics and treatment in gastroenterology.